ArticleOncoTargets and therapy2023

Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.